Italia markets open in 1 hour 33 minutes

PFE Jan 2026 35.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
6,850,00 (0,00%)
In data: 10:08AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente6,85
Aperto6,85
Denaro0,00
Domanda0,00
Prezzo d'esercizio35,00
Scadenza2026-01-16
Min-Max giorno6,85 - 6,85
Contratto - Min-MaxN/D
Volume1
Open InterestN/D
  • GlobeNewswire

    Arvinas and Pfizer Announce Upcoming Vepdegestrant (ARV-471) Poster Presentation at ESMO Congress 2023

    NEW HAVEN, Conn. and NEW YORK, Oct. 15, 2023 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN) and Pfizer Inc. (NYSE: PFE) today announced they will present updated Phase 1/2 data for vepdegestrant (ARV-471) at the 2023 European Society for Medical Oncology (ESMO) Annual Congress. Vepdegestrant is a novel oral PROTAC® estrogen receptor (ER) degrader that is being jointly developed by Arvinas and Pfizer for the treatment of patients with locally advanced or metastatic ER positive/human epidermal g